Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 318685-01-7 | MDL No. : | MFCD06014061 |
Formula : | C12H8ClF2NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NQGTXOOKGUUMFE-UHFFFAOYSA-N |
M.W : | 271.65 | Pubchem ID : | 1511944 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 62.76 |
TPSA : | 39.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.66 cm/s |
Log Po/w (iLOGP) : | 2.6 |
Log Po/w (XLOGP3) : | 3.24 |
Log Po/w (WLOGP) : | 4.18 |
Log Po/w (MLOGP) : | 3.25 |
Log Po/w (SILICOS-IT) : | 4.13 |
Consensus Log Po/w : | 3.48 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.78 |
Solubility : | 0.0452 mg/ml ; 0.000167 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.74 |
Solubility : | 0.0499 mg/ml ; 0.000184 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -5.36 |
Solubility : | 0.00119 mg/ml ; 0.0000044 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.09 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In diethyl ether; ethanol; water; palladium; triethylamine; | A solution of 52.9 g of <strong>[318685-01-7]ethyl 4-chloro-6,7-difluoroquinoline-3-carboxylate</strong> in 750 cm3 of ethanol, in the presence of 19.7 g of triethylamine, was hydrogenated at atmospheric pressure, at a temperature in the region of 20 C., for 1 hour in the presence of 3 g of 5% palladium on carbon (type D). After removing the catalyst by filtration at high temperature, being concentrated to dryness under reduced pressure (5.2 kPa) at about 50 C., the residue was taken up, with stirring, in 1.2 liters of water, dewatered, and washed 3 times with 200 cm3 of water. It was dissolved in 1 liter of diethyl ether; the ethereal extracts were washed twice with 100 cm3 of water and were dried over sodium sulphate. After filtration and concentration under reduced pressure (5.2 kPa), the compound obtained was recrystallized from 600 cm3 of diisopropyl ether. 42.8 g of ethyl 6,7-difluoroquinoline-3-carboxylate was obtained in the form of white crystals, which melted at 135 C. Ethyl 4-chloro-6,7-difluoroquinoline-3-carboxylate was prepared in the following manner: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.05 equiv. of methyl 3-hydrazinylthiophene-2-carboxylate was added to a solution of 3c in ethanol. After 1.5 hr of stirring at room temperature, the solution was concentrated in vacuo and residue was dissolved in chloroform and washed with aq. Sodium bicarbonate solution, dried and concentrated in vacuo. The resulting solid was suspended in ethanol and stirred with 1N sodium hydroxide solution for 30 minutes, acidified with acetic acid and concentrated in vacuo. The solid was filtered, washed with water, dried and suspended in ethanol. 1N sodium hydroxide was added and the reaction mixture was refluxed for 1 hr, acidified with acetic acid and the crystals were collected by filtration. The yellow solid was combined with copper powder and quinoline and stirred at 190 C. for 1 hour. The copper was removed by filtration and the filtrate was mixed with 1N sodium hydroxide solution, followed by extraction with ether. The separated aqueous layer was treated with active charcoal, acidified with acetic acid to yield compound 41 as yellow solid. 1H-NMR (DMSO-d6) delta (ppm): 7.58 (1H, dd, J=5.22, 3.30 Hz), 7.69 (1H, dd, J=11.26, 7.14 Hz), 7.74 (1H, dd, J=5.22, 1.38 Hz), 7.80 (1H, m), 8.15 (1H, dd, J=10.7, 8.2 Hz), 8.77 (1H, d, J=6.2 Hz). m/z 304.2 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | With bis[rhodium(alpha,alpha,alpha',alpha'-tetramethyl-1,3-benzenedipropionic acid)]; caesium carbonate; In dichloromethane; at 0 - 20℃; | General procedure: X-EDA was synthesized according to a literature procedure.1 This gave X-EDA in a cooled DCM solution (between 1.0 and 1.5 eqiuv). When desired, the solvent was swopped from DCM to tolueneat 0 oC. The cooled X-EDA solution was transferred to an ice-cooled addition funnel (0 oC) and addedslowly dropwise to a stirring solution of the desired 3-Cl-indole (1.0 equiv), Cs2CO3 (1.3 equiv) andRh2(esp)2 (0.01 equiv) in DCM or toluene at ambient temperature. Upon addition, the solution colorchanged from green/purple to orange/brown. Addition time was around 30-60 min. After all X-EDAwas added, the solution was stirred for 30 min. before the solvent was evaporated in vacuo. Thecrude product was dissolved in 30 mL EtOAc and washed with 3 mL H2O and 3 mL saturated NaClsolution. The organic phase was dried with MgSO4, filtered and the solvent evaporated in vacuo. Theresidue was purified using silica gel column chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With bis[rhodium(alpha,alpha,alpha',alpha'-tetramethyl-1,3-benzenedipropionic acid)]; caesium carbonate; In toluene; at 0 - 20℃; | General procedure: X-EDA was synthesized according to a literature procedure.1 This gave X-EDA in a cooled DCM solution (between 1.0 and 1.5 eqiuv). When desired, the solvent was swopped from DCM to tolueneat 0 oC. The cooled X-EDA solution was transferred to an ice-cooled addition funnel (0 oC) and addedslowly dropwise to a stirring solution of the desired 3-Cl-indole (1.0 equiv), Cs2CO3 (1.3 equiv) andRh2(esp)2 (0.01 equiv) in DCM or toluene at ambient temperature. Upon addition, the solution colorchanged from green/purple to orange/brown. Addition time was around 30-60 min. After all X-EDAwas added, the solution was stirred for 30 min. before the solvent was evaporated in vacuo. Thecrude product was dissolved in 30 mL EtOAc and washed with 3 mL H2O and 3 mL saturated NaClsolution. The organic phase was dried with MgSO4, filtered and the solvent evaporated in vacuo. Theresidue was purified using silica gel column chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With ethanol; for 24h;Reflux; | General procedure: To the desired ethyl 4-chloro-quinoline-3-carboxylate derivative (1 - 2 mmol) was added 5 mL dryethanol. This solution was refluxed for 24 h or monitored by TLC analysis. The reaction mixture wascooled after the starting material was fully consumed (judged by TLC) and gave a white precipitation.The white solid was centrifuged, the liquid carefully removed and the solid was washed with EtOAcand centrifuged 2-3 times to leave a pure off-white solid. |
[ 148516-11-4 ]
Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
Similarity: 0.71
[ 318685-41-5 ]
7,8-Difluoroquinoline-3-carboxylic acid
Similarity: 0.71
[ 343-10-2 ]
6-Fluoro-4-hydroxyquinoline-3-carboxylic acid
Similarity: 0.68
[ 318-35-4 ]
Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate
Similarity: 0.66
[ 13720-94-0 ]
Ethyl 4-chloroquinoline-3-carboxylate
Similarity: 0.88
[ 77156-85-5 ]
Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate
Similarity: 0.82
[ 206257-39-8 ]
Ethyl 6-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.80
[ 648449-01-8 ]
Methyl 4-chloroquinoline-6-carboxylate
Similarity: 0.77
[ 1379615-56-1 ]
Ethyl 2-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.77
[ 13720-94-0 ]
Ethyl 4-chloroquinoline-3-carboxylate
Similarity: 0.88
[ 77156-85-5 ]
Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate
Similarity: 0.82
[ 206257-39-8 ]
Ethyl 6-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.80
[ 648449-01-8 ]
Methyl 4-chloroquinoline-6-carboxylate
Similarity: 0.77
[ 1379615-56-1 ]
Ethyl 2-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.77
[ 13720-94-0 ]
Ethyl 4-chloroquinoline-3-carboxylate
Similarity: 0.88
[ 77156-85-5 ]
Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate
Similarity: 0.82
[ 206257-39-8 ]
Ethyl 6-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.80
[ 648449-01-8 ]
Methyl 4-chloroquinoline-6-carboxylate
Similarity: 0.77
[ 1379615-56-1 ]
Ethyl 2-bromo-4-chloroquinoline-3-carboxylate
Similarity: 0.77